Zydus Lifesciences Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

12:43 PM, 22nd Jan 2025

Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS).